Cardiac Toxicity Completed Phase 3 Trials for Dexrazoxane (DB00380)

IndicationStatusPhase
DBCOND0028520 (Cardiac Toxicity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002827Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's DiseaseTreatment
NCT00003937Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic OsteosarcomaTreatment
NCT00005578Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's DiseaseTreatment
NCT01230983Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's LymphomaSupportive Care